NuCana Cash from Investing (Quarterly) Trends

NuCana PLC (NCNA)

3.80 -0.08 (-2.06%) USD | NASDAQ | May 15, 15:26

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	0.0038M
September 30, 2023	3.357M
June 30, 2023	0.0347M
March 31, 2023	0.1981M
December 31, 2022	0.1957M
September 30, 2022	0.1101M
June 30, 2022	0.024M
March 31, 2022	-0.1811M
December 31, 2021	-0.6276M
September 30, 2021	-3.855M
June 30, 2021	-0.2539M
March 31, 2021	-0.1627M
December 31, 2020	-0.2262M
September 30, 2020	-0.7905M

Date	Value
June 30, 2020	-0.3852M
March 31, 2020	-0.2833M
December 31, 2019	-0.0595M
September 30, 2019	0.0452M
June 30, 2019	-0.1879M
March 31, 2019	0.0169M
December 31, 2018	-0.2967M
September 30, 2018	-0.0009M
June 30, 2018	-0.425M
March 31, 2018	-0.146M
December 31, 2017	-0.1731M
September 30, 2017	-0.5215M
June 30, 2017	-0.2747M
March 31, 2017	-0.2353M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-3.855M

Minimum

Sep 2021

3.357M

Maximum

Sep 2023

-0.1602M

Average

-0.1627M

Median

Mar 2021

Cash from Investing (Quarterly) Benchmarks

Adaptimmune Therapeutics PLC	68.20M
Biodexa Pharmaceuticals Plc	--
Autolus Therapeutics PLC	-1.477M
Mereo BioPharma Group PLC	--
Bicycle Therapeutics PLC	-0.012M

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	0.4825M
Cash from Financing (Quarterly)	-0.0533M
Free Cash Flow	-33.49M
Free Cash Flow Per Share (Quarterly)	0.1751
Free Cash Flow Yield	-419.1%